摘要
背景:癌症是世界上死亡的主要原因之一。尚未有效治愈,对目前的化疗仍然是一大挑战。 目的:本综述总结了最新的关于可能的应用phytosome配合物在癌症治疗,他们的配方技术,通过phytosome运输机制的调查。 结果:纳米技术通过修改药物及其载体的重要性质开辟了癌症治疗的先驱领域。纳米技术利用各种纳米结构将抗癌剂运送到作用部位。纳米细胞体的更高的稳定性是由于磷脂分子和植物活性剂之间形成化学连接。在几种新的药物递送系统中,植脂体描绘了将植物活性化合物递送至目标作用部位的先进技术,目前,几种植物成分制剂正在临床使用。 结论:植物体配方可增强植物成分的潜在抗癌特性。
关键词: 癌症,药物递送,纳米载体,磷脂,phytosome,抗癌剂。
图形摘要
Current Drug Targets
Title:Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy
Volume: 19 Issue: 2
关键词: 癌症,药物递送,纳米载体,磷脂,phytosome,抗癌剂。
摘要: Background: Cancer is one of the main causes of death in the world. It has not yet been cured in an efficient manner and has remained a major challenge for current chemotherapy.
Objective: This review summarizes the latest investigations regarding the possible application of phytosome complexes for cancer therapy, their formulation techniques, and mechanism of transportation through phytosome.
Results: Nanotechnology opened a pioneer field in cancer therapy by modifying significant properties of drugs and their carriers. Nanotechnology utilizes various nanostructures to transport anti-cancer agents to the site of action. The greater stability of nanophytosomes is due to formation of chemical links between phospholipid molecules and phytoactive agents. Among several new drug delivery systems, phytosomes depict an advanced technology to deliver phytoactive compounds to the target site of action, and at present, several phytosome formulations are in clinical use.
Conclusion: Potential anti-cancer properties of phytoconstituents are enhanced by phytosomal formulations.
Export Options
About this article
Cite this article as:
Nano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170508095250
DOI https://dx.doi.org/10.2174/1389450118666170508095250 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Platelets in Alzheimer’s Disease-Associated Cellular Senescence and Inflammation
Current Pharmaceutical Design Merkel Cell Carcinoma – Current State and the Future
Current Cancer Therapy Reviews Pharmacokinetics-based Dose Management of 5-Fluorouracil Clinical Research in Advanced Colorectal Cancer Treatment
Mini-Reviews in Medicinal Chemistry Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Current Drug Targets The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma
Current Gene Therapy Identification of Disease-Relevant Genes for Molecularly-Targeted Drug Discovery
Current Cancer Drug Targets In Silico Approach to Finding New Active Compounds from Histone Deacetylase (HDAC) Family
Current Pharmaceutical Design Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors
Current Pharmaceutical Design Stereoselective Synthesis and Antiproliferative Activity of Monoterpene-Fused 2- Imino-1,3-oxazines
Current Organic Synthesis Editorial [ Hot Topic: Therapeutic Potential of Peptide Motifs - Part III (Executive Editor: Jean-Claude Herve) ]
Current Pharmaceutical Design Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle
Current Medicinal Chemistry Anticancer Drugs Targeting the Apoptotic Pathway
Medicinal Chemistry Reviews - Online (Discontinued) Involvement of Cysteine Protease Inhibitors in the Defense Mechanism Against Parasites
Medicinal Chemistry The PI3 Kinase Signaling Pathway in Prostate Cancer
Current Cancer Drug Targets Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Utilizing ICG Spectroscopical Properties for Real-Time Nanoparticle Release Quantification <i>In vitro</i> and <i>In vivo</i> in Imaging Setups
Current Pharmaceutical Design